These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14587067)

  • 1. Interaction of clinically important human DNA topoisomerase I poison, topotecan, with double-stranded DNA.
    Streltsov S; Oleinikov V; Ermishov M; Mochalov K; Sukhanova A; Nechipurenko Y; Grokhovsky S; Zhuze A; Pluot M; Nabiev I
    Biopolymers; 2003; 72(6):442-54. PubMed ID: 14587067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction of topotecan, DNA topoisomerase I inhibitor, with double-stranded polydeoxyribonucleotides. 4. Topotecan binds preferably to the GC base pairs of DNA].
    Strel'tsov SA; Mikheĭkin AL; Grokhovskiĭ SL; Oleĭnikov VA; Kudelina IA; Zhuze AL
    Mol Biol (Mosk); 2002; 36(5):912-30. PubMed ID: 12391856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interaction of topotecan-a DNA topoisomerase I inhibitor-with dual-stranded polydeoxyribonucleotides. V. Topotecan is able to cause single- and double-strand breaks in ring superhelical DNA in the absence of enzyme].
    Grokhovskiĭ SL; Strel'tsov SA; Zhuze AL
    Mol Biol (Mosk); 2003; 37(6):1045-54. PubMed ID: 14714500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction of topotecan--a DNA topoisomerase inhibitor--with dual-stranded polydeoxyribonucleotides. I. Dimerization of topotecan in solution].
    Strel'tsov SA; Grokhovskiĭ SL; Kudelina IA; Oleĭnikov VA; Zhuze AL
    Mol Biol (Mosk); 2001; 35(3):432-41. PubMed ID: 11443925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interaction of topotecan, DNA topoisomerase I inhibitor, with double-stranded polydeoxyribonucleotides. III. Binding at the minor groove].
    Strel'tsov SA; Mikheĭkin AL; Grokhovskiĭ SL; Oleĭnikov VA; Zhuze AL
    Mol Biol (Mosk); 2002; 36(3):511-24. PubMed ID: 12068638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interaction of topotecan--a DNA topoisomerase I inhibitor--with dual-stranded polydeoxyribonucleotides. II. Formation of a complex containing several DNA molecules in the presence of topotecan].
    strel'tsov SA; Mikheĭkin AL; Nechipurenko IuD
    Mol Biol (Mosk); 2001; 35(3):442-50. PubMed ID: 11443926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topotecan lactone selectively binds to double- and single-stranded DNA in the absence of topoisomerase I.
    Yao S; Murali D; Seetharamulu P; Haridas K; Petluru PN; Reddy DG; Hausheer FH
    Cancer Res; 1998 Sep; 58(17):3782-6. PubMed ID: 9731484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action models for the antitumor drug camptothecin: formation of alkali-labile complex with DNA and inhibition of human DNA topoisomerase I.
    Streltsov SA
    J Biomol Struct Dyn; 2002 Dec; 20(3):447-54. PubMed ID: 12437383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA binding induces conformational transition within human DNA topoisomerase I in solution.
    Oleinikov V; Sukhanova A; Mochalov K; Ustinova O; Kudelina I; Bronstein I; Nabiev I
    Biopolymers; 2002; 67(6):369-75. PubMed ID: 12209444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal encapsulation increases the activity of the topoisomerase I inhibitor topotecan.
    Subramanian D; Muller MT
    Oncol Res; 1995; 7(9):461-9. PubMed ID: 8835290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells.
    Traganos F; Kapuscinski J; Gong J; Ardelt B; Darzynkiewicz RJ; Darzynkiewicz Z
    Cancer Res; 1993 Oct; 53(19):4613-8. PubMed ID: 8402636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of topotecan to a nicked DNA oligomer in solution.
    Bocian W; Kawecki R; Bednarek E; Sitkowski J; Williamson MP; Hansen PE; Kozerski L
    Chemistry; 2008; 14(9):2788-94. PubMed ID: 18214879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I.
    Antony S; Jayaraman M; Laco G; Kohlhagen G; Kohn KW; Cushman M; Pommier Y
    Cancer Res; 2003 Nov; 63(21):7428-35. PubMed ID: 14612542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topotecan-induced alterations in the amount and stability of human DNA topoisomerase I in solid tumor cell lines.
    Devy J; Wargnier R; Pluot M; Nabiev I; Sukhanova A
    Anticancer Res; 2004; 24(3a):1745-51. PubMed ID: 15274350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex.
    Staker BL; Feese MD; Cushman M; Pommier Y; Zembower D; Stewart L; Burgin AB
    J Med Chem; 2005 Apr; 48(7):2336-45. PubMed ID: 15801827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of resistance to topoisomerase I-targeting drugs.
    Rasheed ZA; Rubin EH
    Oncogene; 2003 Oct; 22(47):7296-304. PubMed ID: 14576839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of camptothecin-induced topoisomerase I cleavage complexes by the acetaldehyde adduct N2-ethyl-2'-deoxyguanosine.
    Antony S; Theruvathu JA; Brooks PJ; Lesher DT; Redinbo M; Pommier Y
    Nucleic Acids Res; 2004; 32(18):5685-92. PubMed ID: 15498925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
    Smith LM; Willmore E; Austin CA; Curtin NJ
    Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human topoisomerase I forms double cleavage complexes on natural DNA.
    Søe K; Hartung S; Grosse F
    Biochem Biophys Res Commun; 2006 Oct; 349(1):178-85. PubMed ID: 16930551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-azacamptothecin: a potent water-soluble topoisomerase I poison.
    Cheng K; Rahier NJ; Eisenhauer BM; Gao R; Thomas SJ; Hecht SM
    J Am Chem Soc; 2005 Jan; 127(3):838-9. PubMed ID: 15656613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.